Novo-Nordisk A/S (NVO)
NYSE · American depositary receipt
As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow NVO in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on NVO and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
NVO at a glance
Key statistics
$173.66B
Market capitalization
- Previous close
- $39.35
- Open
- $39.27
- Day range
- $39.09 – $39.46
- Volume
- 3.74M
- Average volume (30 sessions)
- 13.40M
- Shares outstanding
- 3.39B
- Beta (1 year, vs SPY)
- 1.03
Where the price sits in its year
52-week range
14% of the range
- Below the 52-week high
- -38.8%
- Above the 52-week low
- +11.8%
Completed sessions through Oct 20, 2026
Technical snapshot
Below its 50-day and 200-day averages
- 20-day average
- $38.30+2.7%
- 50-day average
- $42.36-7.1%
- 200-day average
- $44.94-12.4%
Between the conventional 30 and 70 bands.
+3.4%
1 week
-1.1%
1 month
-18.3%
3 months
-22.7%
Year to date
-27.6%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with NVO
NVO on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on NVO.
See the plans →
Every planScreen names like NVO
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on NVO
Put NVO on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on NVO
See whether there is an open premium alert on NVO, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
NVO headlines
No headlines on the wire for NVO in recent weeks.
SEC Form 4, most recent first
Insider filings
No insider transactions reported for NVO recently. ETFs and many foreign issuers do not file Form 4.
About Novo-Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
- Exchange
- NYSE
- Security
- American depositary receipt
- Employees
- 69,500
- Listed since
- Apr 30, 1981
- Website
- novonordisk.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.